Technical Analysis for TLC - Taiwan Liposome Company, Ltd.

Grade Last Price % Change Price Change
grade F 5.0101 -0.99% -0.05
TLC closed down 0.99 percent on Tuesday, September 17, 2019, on 81 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical TLC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -0.99%
50 DMA Resistance Bearish -0.99%
Stochastic Reached Oversold Weakness -0.99%
Oversold Stochastic Weakness -0.99%
20 DMA Resistance Bearish 0.20%
50 DMA Resistance Bearish 0.20%
New Uptrend Bullish 0.20%

Older signals for TLC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Taiwan Liposome Company, Ltd., a biopharmaceutical company, engages in the research, development, and commercialization of lipid-based pharmaceutical products. The company offers products in the areas of oncology, ophthalmology, peripheral arterial disease, fungal infection, anesthetic, and arthritis indications. Its products include Lipotecan, an anti-cancer camptothecin drug; Doxisome, a liposomal encapsulated formulation of doxorubicin; TLC178, a liposomal encapsulated formulation of vinorelbine; ProDex, an ophthalmic drug for the treatment of macular edema; ProFlow, an emulsion form of prostaglandin E1; AmBiL, a liposomal encapsulated formulation of amphotericin B; TLC198, a liposomal encapsulated bupivacaine, enabling the sustained release of a constant amount of local anesthetic; and TLC599, a corticosteroid encapsulated in lipid based drug delivery system for the treatment of inflammation caused by arthritis. The company was founded in 1997 and is headquartered in Taipei City, Taiwan.
Biopharmaceutical Drugs Inflammation Pharmacology Drug Delivery Arthritis Macular Edema Doxorubicin Peripheral Arterial Disease Amphotericin B Arbutus Biopharma Bupivacaine Liposome
Is TLC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.0
52 Week Low 4.88
Average Volume 744
200-Day Moving Average 0.0
50-Day Moving Average 5.1969
20-Day Moving Average 5.1837
10-Day Moving Average 5.087
Average True Range 0.2508
ADX 25.72
+DI 32.8262
-DI 22.3466
Chandelier Exit (Long, 3 ATRs ) 4.7476
Chandelier Exit (Short, 3 ATRs ) 5.6324
Upper Bollinger Band 5.512
Lower Bollinger Band 4.8554
Percent B (%b) 0.24
BandWidth 12.666628
MACD Line -0.0509
MACD Signal Line -0.0305
MACD Histogram -0.0204
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.51
Resistance 3 (R3) 5.56 5.45 5.42
Resistance 2 (R2) 5.45 5.32 5.42 5.40
Resistance 1 (R1) 5.23 5.25 5.18 5.18 5.37
Pivot Point 5.12 5.12 5.09 5.09 5.12
Support 1 (S1) 4.90 4.99 4.84 4.84 4.65
Support 2 (S2) 4.79 4.92 4.76 4.62
Support 3 (S3) 4.57 4.79 4.60
Support 4 (S4) 4.51